Amneal Pharmaceuticals

September 29, 2016

Represented Amneal Pharmaceuticals in a Hatch-Waxman patent litigation concerning a drug for treating pain. Appeals in the Federal Circuit are ongoing. 

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Similar Results

Back to Top